Targeted Therapies in Lung Cancer Patient Forum 2017 Webcast Details

                                                   


Welcome to the 2017 Targeted Therapies in Lung Cancer Patient Forum Live Webcast

View Speaker Bios                         View the Agenda                         Download Speaker presentations & handouts

 

*Please Note, you may need to pause feeds of sessions you are not watching to avoid duplicate video transmissions*

8:30 – 10am

      

General Session

 The Many Faces of Progression
 Dr. Nathan Pennell,  Cleveland Clinic Cancer Center

 The Role of Local Therapy

 Dr. Shirish Gadgeel, Michigan Medicine, University of Michigan

 Biopsies & Re-biopsies
 Dr. Karen Reckamp, City of Hope Comprehensive Cancer  Center

 

 
 

 

 10 -10:30 am - BREAK (no webcast during this period)   

10:30 - noon

 

 General Session

 The Question of Clinical Trials

 Dr. Alice Shaw

 Massachusetts General Hospital

 The Crossroads:

 Local Therapy, Chemo, Targeted  Therapy, or Immunotherapy?

 Panel Discussion with Drs. Pennell,  Gadgeel, Reckamp, and Shaw,

 and patients John Cherol (EGFR), Matt  Hiznay (ALK),

 and Sara Whitlock (RET).

 Moderator: Dr. H. (Jack) West

 

 

 
 
 

Noon - 1pm - LUNCH (no webcast during this period)

 

1pm - 2:30

 
  Lung Cancer Sub-Type Break-Outs
 
 
   

 ALK/ROS1

 Dr. Alice Shaw, Dr. Shirish Gadgeel,

 and Matt Hiznay, ALK patient

 
 
 
             
 
   

 EGFR

 Dr. Nathan Pennell, Dr. H. (Jack) West,

 and John Cherol, EGFR patient

 
 coming soon
 
             
 
   
 
 
 
 

 MET/RET/BRAF

 Dr. Karen Reckamp, Dr. Vamsidhar  Velcheti, and Sara Whitlock, RET patient

 

 
 
 
 
 
 
 
 

 

2:30 - 2:50 pm - BREAK (no webcast during this period) 
 

2:50 – 4pm

 

 General Session

 Managing the Cost of Cancer Care
 Dr. James P. Stevenson
 Cleveland Clinic Cancer Center

 Patient to Patient Mentoring
 Kathryn Sefcek, MHA
 4th Angel Mentoring Program

Caveat Emptor: Assessing Cancer Information from Sources of Varying Quality  
 Dr. H. (Jack) West
 Swedish Cancer Institute & Founder of  cancerGRACE
 and Janet Freeman-Daily, ROS1 patient,  #LCSM Twitter Chat co- moderator, Cure  Today contributor, blogger

 
 

  

GRACE would like to thank the following companies for their support of this forum: